Compare
Edwards Lifesciences vs Medtronic (EW vs MDT)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Edwards Lifesciences (EW) returned +23.3% and Medtronic (MDT) +12.6%; so far this year the figures are +19.8% and +6.0%.
Medtronic is the larger company by market value, about 2.2 times the size of Edwards Lifesciences.
On trailing earnings, EW trades at 57.7 times and MDT at 25.0 times.
Revenue grew +13.4% at EW and +9.8% at MDT over the last year.
EW pays no dividend. MDT yields 2.81%.
Data as of the latest close. Not investment advice.
Relative performance
| EW | MDT | |
|---|---|---|
| Price | $102.14 | $101.80 |
| 1-day | +1.31% | -2.90% |
| YTD | +19.81% | +5.98% |
| 1 year | +23.30% | +12.61% |
| 3 years | +60.02% | +43.68% |
| Market cap | $58.7B | $130.2B |
| P/E | 57.7 | 25.0 |
| P/S | 8.80 | 3.47 |
| P/B | 5.41 | 2.59 |
| Revenue growth | +13.40% | +9.80% |
| EPS growth | -23.70% | +12.10% |
| Gross margin % | 78.0 | 65.0 |
| Net margin % | 15.3 | 13.9 |
| ROE % | 9.4 | 10.4 |
| Debt / equity | 0.06 | 0.56 |
| FCF yield % | 2.4 | 4.7 |
| Dividend yield % | — | 2.81 |
| Beta | 0.52 | 0.14 |
| RSI (14) | 76.8 | 63.8 |
| Technical rating |